Ovarian reserve unchanged by hydroxyurea in sickle cell disease, study reveals

FHS
July 18, 2024
11:50 pm

In female patients living with sickle cell disease (SCD), hydroxyurea had no effect on ovarian reserve, suggesting that fertility preservation measures prior to treatment may be unnecessary, according to a study published in Blood Advances.

XNK Therapeutics’ evencaleucel gets EMA recommendation

Share this article Supporting XNK Therapeutics’ work is a team that includes experts in NK cell research. Credit: Gorodenkoff/Shutterstock.com. XNK Therapeutics, a Sweden-based immunotherapy company,

January 16, 2024

Soft, wearable robot helps a person with Parkinson’s to walk without freezing

Freezing is one of the most common and debilitating symptoms of Parkinson’s disease, a neurodegenerative disorder that affects more than 9 million people worldwide.

January 5, 2024

Ultragenyx Pharmaceutical opens new gene therapy plant in US

The exterior panels on Ultragenyx’s new gene therapy manufacturing facility in Bedford, Massachusetts, are a representation of the sequenced human genome. Credit: Ultragenyx Pharmaceutical Inc.

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.